Yasuhiro Mitsuuchi

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index3.8kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell death mechanisms and regulation(14), interferon and immune responses(12), Cancer-related Molecular Pathways(10), RNA Interference and Gene Delivery(10), NF-κB Signaling Pathways(9)

Publications68 total

Supplementary Figures 1 - 7, Table 1 from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Table 2 from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Figure Legends from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Data from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Figures 1 - 7, Table 1 from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Table 2 from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Figure Legends from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Data from Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models
2023Open Access
Supplementary Figure S3 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S1 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S2 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S5 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Data from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S4 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S1 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Table S1 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Data from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S4 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Figure S5 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
Supplementary Table S1 from The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Christopher A. Benetatos(16), Srinivas K. Chunduru(16), Mark A. McKinlay(15), Eric M. Neiman(13), Yutaka Shizuta(12), Joseph R. Testa(11), Takeshi Kawamoto(11), Katsumi Toda(11), Stephen M. Condon(10), Gurpreet S. Kapoor(9), Yuichi Yokoyama(8), Guangyao Yu(7), Martin A. Graham(7), Hiroo Imura(6), Jennifer M. Burns(6), Martin E. Seipel(6), Kaoru Miyahara(6), Yasutake Yamamoto(6), Clemens Krepler(6), Molly B. Halloran(6)